A recent study conducted by numerous renowned hospitals and medical organizations confirms that surgery is still the leader in treating mesothelioma. The study, performed by researchers from North Shore/Long Island Jewish Health System, Hofstra School of Medicine and Mount Sinai Medical Center, included patients already confirmed with malignant mesothelioma. The purpose of the study was to determine which […]

Read More

Researchers have recently discovered that an immunotherapy drug intended to treat melanoma has shown to be extremely powerful in stopping cancerous tumor growth in pleural mesothelioma patients. Scientists and researchers at Pennsylvania’s University School of Medicine and physicians from Europe recently provided results of their ongoing study on Keytruda, a prescription medicine originally used for melanoma. […]

Read More